XML 27 R16.htm IDEA: XBRL DOCUMENT v3.19.2
Legal Proceedings
6 Months Ended
Jun. 30, 2019
Commitments And Contingencies Disclosure [Abstract]  
Legal Proceedings

11. Legal Proceedings

 

On June 3, 2019, a purported federal securities class action complaint was filed against the Company, its Chief Executive Officer and Chief Financial Officer by Jimmy Wong, individually and on behalf of all others similarly situated (the “Plaintiff”), in the United States District Court for the Southern District of California (the “Complaint”). In the Complaint, the Plaintiff alleges certain violations of federal securities laws in connection with the decline in market value of the Company’s securities following the Company’s announcement of its receipt of a CRL from the FDA regarding the NDA for HTX-011. The Plaintiff seeks class action certification, damages in an unspecified amount, prejudgment and post-judgment interest, fees and costs and such other relief as the United States District Court for the Southern District of California may deem just and proper. The Company intends to defend itself vigorously in the case. Due to the early stage of this proceeding, we are not able to predict or reasonably estimate the outcome or possible losses relating to this matter.